Kraków, Poland – 03 October 2017 – Selvita Chief Scientific Officer and Executive VP, dr Krzysztof Brzozka, will present together with dr Monica Binaschi, Head of the Pharmacology Department at Menarini Ricerche, during the Advances
in Oncology session at the upcoming European Business Development Conference which will take place in Heidelberg,
10 -11 October 2017.

The session will take place on the 1st day of conference, October 10, starting at 13:45.

Dr Binaschi and dr Brzozka will be joined in the discussion by dr Niels Emmerich from Abbvie, dr Steve Megit from Immunocore and dr Sandra von Meier from Merck.

More information on the conference available here.